SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: pocotrader5/27/2021 12:26:38 AM
   of 1574999
 
New Pfizer vaccine storage time increases access New guidelines mean less expired doses, easier distribution and potentially increases the number of people who can be vaccinated.


Jessica Bouchard
The European Medicines Agency (EMA) has officially updated the storage recommendations for the Pfizer-BioNTech vaccine. The change will allow for the vaccine to be stored at two to eight degrees Celsius — a normal refrigeration temperature — instead of the original minus 70 degrees. The amount of time it could be stored after thawing out has also been extended — from five days to a month.

During the beginning of the Canada’s vaccination campaign, the original storage requirements for the Pfizer vaccine necessitated the use of special freezers which slowed rollout and complicated delivery. Across the country, provinces had to get creative with their vaccine distribution centres.

Quebec, for example, equipped some of their long-term care homes with the special freezers in order to prioritize the older population. In other areas, such as remote territories, the Moderna vaccine — which has fewer storage challenges — was given.

Health Canada on board
Health Canada officially approved the new guidelines last week, following the release of the EMA’s announcement.

“This approval allows significantly more flexibility in the distribution of the Pfizer-BioNTech COVID-19 vaccine to clinics across the country while maintaining our ability to deliver large volumes on a consistent basis,” Christina Antoniou, Pfizer Canada’s director of corporate affairs, told CBC News.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext